FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1

FDA Approves Rozlytrek Companion Diagnostic

FDA approves a Foundation Medicine blood-based companion diagnostic for Genentechs cancer drug Rozlytrek.

latest-news-card-1
Biologics

Group Urges Postponement of Alzheimers Drug Decision

Public Citizen calls on FDA to postpone a 1/6-expected accelerated approval decision on a Biogen/Eisai Alzheimers drug until after an advisory committ...

latest-news-card-1
Human Drugs

Build Flexibility into Pubertal Development Guidance: BIO

The Biotechnology Innovation Organization suggests modifications to an FDA draft guidance on measuring growth and evaluating pubertal development in p...

latest-news-card-1
Human Drugs

AstraZeneca BLA for RSV Prevention in Infants

FDA accepts for review an AstraZeneca BLA for nirsevimab for preventing respiratory syncytial virus lower respiratory tract disease in newborns and in...

latest-news-card-1
Federal Register

3 Federal Register Notices on New Device Classifications

FDA publishes three Federal Register notices on device classifications related to de novo requests.

latest-news-card-1
Human Drugs

Lupin Recalls 4 Quinapril Lots

FDA says Lupin recalled one lot of 20 mg Quinapril tablets and three lots of 40 mg tablets due to the potential presence of N-Nitroso-Quinapril, a nit...

latest-news-card-1
Animal Drugs

FDA Approves Zycosan for Horses with Osteoarthritis

FDA approves the first injectable pentosan product for use in horses with osteoarthritis.

latest-news-card-1
Medical Devices

Reverse Calif. Consumer Protection Regime: WLF

Washington Legal Foundation asks the Supreme Court to reverse a California appeals court decision that hit Ethicon with $300 million in civil penaltie...

Human Drugs

Genentechs Lunsumio OKd for Some Lymphomas

FDA gives accelerated approval to Genentechs Lunsumio to treat some forms of follicular lymphoma.

Human Drugs

FDA Approves Gileads Sunlenca for Some HIV Patients

FDA approves Gileads Sunlenca, the first in a new class of drugs to treat some HIV-1 patients.